Position in CRNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,861,157
+$560,143 QoQ
Shares Held
129,908
+9.7% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CRNX ranks #50 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,861,157 | 129,908 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,301,014 | 118,420 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,388,255 | 115,752 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,477,891 | 131,522 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,891,429 | 135,307 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,425,603 | 131,950 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $6,344,108 | 124,078 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $5,555,540 | 108,719 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,030,768 | 112,319 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $5,087,919 | 108,693 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,814,709 | 107,215 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,168,915 | 106,554 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,624,575 | 90,154 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,315,378 | 81,904 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,445,480 | 78,988 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,551,461 | 78,995 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,371,819 | 73,556 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,047,036 | 47,701 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,222,965 | 43,047 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $745,233 | 35,403 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $632,436 | 33,551 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $433,906 | 28,397 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $434,122 | 30,767 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $438,556 | 27,987 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $572,150 | 32,657 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $186,660 | 12,698 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||